CVRx, Inc. Effective Income Tax Rate Reconciliation, Tax Contingency, Percent
CVRx, Inc. (CVRX) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Percent of -0.20% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies · last filed 2026-02-13
- CVRx, Inc. effective income tax rate reconciliation, tax contingency, percent for fiscal 2024 was -0.20%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent 12 month |
|---|---|
| 2024-12-31 | -0.20% 10-K · filed 2026-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |